As we’ve written before, we tend – deliberately – not to focus on charities that are small and/or “experimental” in nature. From what we’ve seen, these charities rarely can demonstrate that their program has “worked” (in the sense of changing lives) before, and so the only way to evaluate them is to have a deep…
The GiveWell Blog
All International charity Posts
2008-2009 international aid recommendations
Our 2008-2009 recommendations for international aid are now available. Report homepage Recommended and top-rated charities Highlights: We believe that health is the best area for an individual donor looking to accomplish concrete good. Many programs have strong and proven track records of success in international aid. This is largely not true of other areas. More…
Clarifying the role of different partners
One major question we’ve struggled to answer is: how do the different NGOs, local governments, and international global health partnerships work together to implement a given program? For example, take mass drug administration of ivermectin to reduce onchocerciasis, one of our favorite programs. In Uganda, the African Programme for Onchocerciasis Control (APOC) works out of…
Aid’s track record
While Elie’s been investigating the Carter Center, I’ve been scanning literature (mostly academic) on general questions about aid: what has worked in the past? What’s promising for the future? etc. Rather than trying to come to an independent conclusion on each debate, I’ve been trying to establish which beliefs are supported by evidence that is…
Malaria “success story” questioned
Aid Watch on questionable claims of success against malaria: Real victories against malaria would be great, but false victories can mislead and distract critical malaria efforts. Alas, Mr. and Mrs. Gates are repeating numbers that have already been discredited. This story of irresponsible claims goes back to a big New York Times headline on February…
Trachoma: An example of the need for long-term monitoring
When is a measured program-impact not a real impact? When it doesn’t last. A study published today in PloS NTDs evaluated the impact of four doses of azithromycin (one every 6 months), and monitored trachoma prevalence throughout the drug administration period and for 2 years after the last dose. In the first 24 months (from…